ERBB2 and neoplasm: HER2-expression heterogeneity can be identified at three different levels: (a) inter-tumor heterogeneity among tumors of different patients classified as HER2-positive; (b) inter-lesion heterogeneity between primary tumor and metastasis in the same patient; (c) intra-tumor heterogeneity within single lesions.